VAIA, PAOLO
VAIA, PAOLO
Dipartimento di Medicina di Precisione
Beneficial Effects of Long-Lasting Bicarbonate–Sulfate–Calcium–Magnesium Water Intake on Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Related Outcomes via Impacting Intestinal Permeability (IP), IP-Related Systemic Inflammation, and Oxidative Stress
2025 Dallio, Marcello; Romeo, Mario; Di Nardo, Fiammetta; Senese, Giusy; Silvestrin, Alessia; Coppola, Annachiara; Napolitano, Carmine; Vaia, Paolo; Basile, Claudio; Martinelli, Giuseppina; Gregorio, Alessia De; Federico, Alessandro
Clinical Applications of Artificial Intelligence (AI) in Human Cancer: Is It Time to Update the Diagnostic and Predictive Models in Managing Hepatocellular Carcinoma (HCC)?
2025 Romeo, M.; Dallio, M.; Napolitano, C.; Basile, C.; Di Nardo, F.; Vaia, P.; Iodice, P.; Federico, A.
Dysgeusia in MASLD-related advanced chronic liver disease (ACLD): a silent driver towards the "Bermuda" triangle of malnutrition-sarcopenia-frailty severely affecting prognosis
2025 Dallio, M.; Romeo, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Iadanza, G.; Olivieri, S.; Coppola, A.; Niosi, M.; Federico, A.
Exploring the Epidemiologic Burden, Pathogenetic Features, and Clinical Outcomes of Primary Liver Cancer in Patients with Type 2 Diabetes Mellitus (T2DM) and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Scoping Review
2025 Romeo, Mario; Di Nardo, Fiammetta; Napolitano, Carmine; Basile, Claudio; Palma, Carlo; Vaia, Paolo; Dallio, Marcello; Federico, Alessandro
FLAME: Training and Validating a Newly Conceived Model Incorporating Alpha-Glutathione-S-Transferase Serum Levels for Predicting Advanced Hepatic Fibrosis and Acute Cardiovascular Events in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2025 Dallio, M.; Romeo, M.; Di Nardo, F.; Vaia, P.; Napolitano, C.; Ventriglia, L.; Coppola, A.; Silvestrin, A.; Olivieri, S.; Federico, A.
From “Traditional” to “Trained” Immunity: Exploring the Novel Frontiers of Immunopathogenesis in the Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2025 Romeo, Mario; Silvestrin, Alessia; Senese, Giusy; Di Nardo, Fiammetta; Napolitano, Carmine; Vaia, Paolo; Coppola, Annachiara; Federico, Pierluigi; Dallio, Marcello; Federico, Alessandro
Letter: Different Risk of Acute Variceal Bleeding According to the Liver Disease Aetiology in Decompensated Cirrhosis Patients Receiving Carvedilol‐Based Primary Prophylaxis—May Insulin Resistance Unloose This Gordian Knot?
2025 Romeo, Mario; Di Nardo, Fiammetta; Napolitano, Carmine; Vaia, Paolo; Federico, Alessandro; Dallio, Marcello
Managing Ascites and Kidney Dysfunction in Decompensated Advanced Chronic Liver Disease: From “One Size Fits All” to a Multidisciplinary-Tailored Approach
2025 Romeo, Mario; Napolitano, Carmine; Vaia, Paolo; Di Nardo, Fiammetta; Borrelli, Silvio; Garofalo, Carlo; De Nicola, Luca; Federico, Alessandro; Dallio, Marcello
Nutritional and Psychological Support as a Multidisciplinary Coordinated Approach in the Management of Chronic Liver Disease: A Scoping Review
2025 Romeo, Mario; Dallio, Marcello; Cipullo, Marina; Coppola, Annachiara; Mazzarella, Chiara; Mammone, Simone; Iadanza, Giorgia; Napolitano, Carmine; Vaia, Paolo; Ventriglia, Lorenzo; Federico, Alessandro
Phase Angle/C-reactive Protein-Index as a Novel Combined Tool for Predicting Liver-Related Hospitalizations in MASLD-Decompensated Cirrhosis
2025 Dallio, Marcello; Romeo, Mario; Coppola, Annachiara; Martinelli, Giuseppina; Basile, Claudio; Di Nardo, Fiammetta; Napolitano, Carmine; Vaia, Paolo; De Gregorio, Alessia; Silvestrin, Alessia; Senese, Giusy; Federico, Alessandro
Primary biliary cholangitis, Celiac Disease, and MASLD: the triumvirate of steatosis. How should we manage this triple overlap?
2025 Romeo, M.; Nardo, F. D.; Napolitano, C.; Vaia, P.; Federico, A.; Dallio, M.
Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis
2024 Dallio, M.; Romeo, M.; Vaia, P.; Auletta, S.; Mammone, S.; Cipullo, M.; Sapio, L.; Ragone, A.; Niosi, M.; Naviglio, S.; Federico, A.
Spleen Area Affects the Performance of the Platelet Count–Based Non-invasive Tools in Predicting First Hepatic Decompensation in Metabolic Dysfunction–Associated Steatotic Liver Disease Cirrhosis
2025 Dallio, M.; Romeo, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Olivieri, S.; Niosi, M.; Federico, A.
Systemic Oxidative Balance Reflects the Liver Disease Progression Status for Primary Biliary Cholangitis (Pbc): The Narcissus Fountain
2024 Dallio, M.; Romeo, M.; Cipullo, M.; Ventriglia, L.; Scognamiglio, F.; Vaia, P.; Iadanza, G.; Coppola, A.; Federico, A.
Systemic Oxidative Stress Correlates with Sarcopenia and Pruritus Severity in Primary Biliary Cholangitis (PBC): Two Independent Relationships Simultaneously Impacting the Quality of Life—Is the Low Absorption of Cholestasis-Promoted Vitamin D a Puzzle Piece?
2024 Dallio, M.; Romeo, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Ventriglia, L.; Coppola, A.; Olivieri, S.; Niosi, M.; Federico, A.
The Role of the Gut–Biliary–Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications
2025 Romeo, M.; Dallio, M.; Di Nardo, F.; Napolitano, C.; Vaia, P.; Martinelli, G.; Federico, P.; Olivieri, S.; Iodice, P.; Federico, A.